Addition Therapeutics
Develops RNA-based gene therapies for chronic and rare diseases.
biotechpharmaceuticals
Company facts
- Founded
- 2021
- Employees
- 50
- Headquarters
- United States
- Type
- Private
- Funding
- Series A · $100M · 2025
Open positions
1 job
Search jobs inside your AI agent.
Connect over MCP — free, no account needed to search.
Develops RNA-based gene therapies for chronic and rare diseases.
Company facts